Russell Alan J
Chief Scientific Officer at EWTX
- Sold, on record
- $23.5M
- Dollars the filings state
- Form 4 sales
- 23
- Latest Aug 12, 2026
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EWTXEdgewise Therapeutics, Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale EWTXNo planAug 12, 2025 2025
Sold 1,907 shares at $13.39 ($26k)
Russell Alan J, Chief Scientific Officer
No 10b5-1 planSold 7.5% of holdings ($339k position)23,400 shares left0.2x usual sizeFiling
- 2 Form 144 notice EWTXNoticeAug 26, 2025 +14 days
Filed to sell 100,000 shares ($1.5M)
Russell Alan J, Officer, Director
No 10b5-1 plan18x usual sizeFiling
- 3 Form 4 sale EWTXUnusualAug 26, 2025 same day
Sold 100,000 shares at $14.60 ($1.5M)
Russell Alan J, Chief Scientific Officer
No 10b5-1 planSold 81% of holdings ($1.8M position)23,400 shares left18x usual sizeFollows a Form 144Filing
- 4 Form 144 notice EWTXNoticeNov 12, 2025 +78 days
Filed to sell 100,000 shares ($2.1M)
Russell Alan J, Officer, Director
No 10b5-1 plan10.9x usual sizeFiling
- 5 Form 4 sale EWTXUnusualNov 12, 2025 same day
Sold 100,000 shares at $21.12 ($2.1M)
Russell Alan J, Chief Scientific Officer
No 10b5-1 planSold 81% of holdings ($2.6M position)23,400 shares left10.9x usual sizeFollows a Form 144Filing
- 6 Form 144 notice EWTXNoticeJul 1, 2026 +231 days
Filed to sell 200,000 shares ($8.1M)
Russell Alan J, Director, Officer
10b5-1 plan4.7x usual sizeFiling
- 7 Form 4 sale EWTXUnusualJul 1, 2026 same day
Sold 200,000 shares at $39.41 ($7.9M)
Russell Alan J, Chief Scientific Officer
10b5-1 planSold 89.1% of holdings ($8.8M position)24,555 shares left4.7x usual sizeFollows a Form 144Filing
- 8 Form 4 sale EWTXNo planAug 12, 2026 +42 days
Sold 5,901 shares at $43.73 ($258k)
Russell Alan J, Chief Scientific Officer
No 10b5-1 planSold 15.8% of holdings ($1.6M position)31,466 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (30)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Aug 14, 2026 | EWTX | Chief Scientific Officer | Form 4 sale | 5,901 | $258k | 15.8% | No plan | SEC |
| Jul 1, 2026 | Jul 2, 2026 | EWTX | Chief Scientific Officer | Form 4 sale | 200,000 | $7.9M | 89.1% | Unusual | SEC |
| Jul 1, 2026 | Jul 1, 2026 | EWTX | Director, Officer | Form 144 notice | 200,000 | $8.1M | Notice | SEC | |
| Nov 12, 2025 | Nov 13, 2025 | EWTX | Chief Scientific Officer | Form 4 sale | 100,000 | $2.1M | 81.0% | Unusual | SEC |
| Nov 12, 2025 | Nov 12, 2025 | EWTX | Officer, Director | Form 144 notice | 100,000 | $2.1M | Notice | SEC | |
| Aug 26, 2025 | Aug 28, 2025 | EWTX | Chief Scientific Officer | Form 4 sale | 100,000 | $1.5M | 81.0% | Unusual | SEC |
| Aug 26, 2025 | Aug 26, 2025 | EWTX | Officer, Director | Form 144 notice | 100,000 | $1.5M | Notice | SEC | |
| Aug 12, 2025 | Aug 14, 2025 | EWTX | Chief Scientific Officer | Form 4 sale | 1,907 | $26k | 7.5% | No plan | SEC |
| May 2, 2025 | May 7, 2025 | EWTX | Chief Scientific Officer | Form 4 sale | 1,551 | $26k | 7.7% | No plan | SEC |
| Mar 7, 2025 | Mar 11, 2025 | EWTX | Chief Scientific Officer | Form 4 sale | 200 | $6k | 1.3% | Routine | SEC |
| Feb 6, 2025 | Feb 7, 2025 | EWTX | Chief Scientific Officer | Form 4 sale | 9,215 | $277k | 38.3% | Routine | SEC |
| Feb 5, 2025 | Feb 5, 2025 | EWTX | Director, Officer | Form 144 notice | 100,000 | $3M | Notice | SEC | |
| Dec 30, 2024 | Dec 31, 2024 | EWTX | Chief Scientific Officer | Form 4 sale | 100,000 | $2.7M | 87.1% | Routine | SEC |
| Dec 30, 2024 | Dec 30, 2024 | EWTX | Director, Officer | Form 144 notice | 100,000 | $2.9M | Notice | SEC | |
| Sep 20, 2024 | Sep 24, 2024 | EWTX | Chief Scientific Officer | Form 4 sale | 75,000 | $2.1M | 85.5% | Unusual | SEC |
| Sep 20, 2024 | Sep 20, 2024 | EWTX | Officer, Director | Form 144 notice | 75,000 | $2.1M | Notice | SEC | |
| May 2, 2024 | May 3, 2024 | EWTX | Chief Scientific Officer | Form 4 sale | 1,576 | $30k | 17.9% | No plan | SEC |
| Dec 26, 2023 | Dec 28, 2023 | EWTX | Chief Scientific Officer | Form 4 sale | 172,585 | $1.6M | 98.0% | Unusual | SEC |
| Dec 26, 2023 | Dec 26, 2023 | EWTX | Officer, Director | Form 144 notice | 172,585 | $1.6M | Notice | SEC | |
| May 2, 2023 | May 3, 2023 | EWTX | Chief Scientific Officer | Form 4 sale | 1,602 | $14k | 0.9% | No plan | SEC |
| Nov 15, 2021 | Nov 17, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 479 | $9k | 100.0% | Unusual | SEC |
| Nov 12, 2021 | Nov 12, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 69,740 | $1.4M | 99.3% | Unusual | SEC |
| Nov 8, 2021 | Nov 8, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 29,451 | $584k | 29.5% | Unusual | SEC |
| Nov 3, 2021 | Nov 3, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 44,172 | $790k | 30.7% | Unusual | SEC |
| Oct 15, 2021 | Oct 18, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 7,182 | $130k | 4.8% | Plan not stated | SEC |
| Oct 11, 2021 | Oct 13, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 1,270 | $23k | 0.8% | Plan not stated | SEC |
| Oct 8, 2021 | Oct 8, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 21,028 | $387k | 12.1% | Plan not stated | SEC |
| Oct 5, 2021 | Oct 5, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 5,778 | $105k | 3.2% | Plan not stated | SEC |
| Sep 29, 2021 | Sep 30, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 26,454 | $452k | 12.9% | Plan not stated | SEC |
| Sep 27, 2021 | Sep 27, 2021 | EWTX | Chief Scientific Officer | Form 4 sale | 58,546 | $1.1M | 22.2% | Plan not stated | SEC |